NCT04362072 2025-06-11Study of Lorlatinib In People With ALK-positive Non-small Cell Lung CancerPfizerPhase 4 Completed71 enrolled 26 charts
NCT00847912 2021-06-11VAKCCTVA Office of Research and DevelopmentPhase 4 Completed954 enrolled 11 charts
NCT01525550 2019-07-30A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsPfizerPhase 4 Completed106 enrolled 26 charts